Guided Therapeutics, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was USD 1.052 million compared to USD 937,000 a year ago. Net loss was USD 279,000 compared to USD 1.921 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.58 a year ago.